KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Enterprise Value (2018 - 2025)

Historic Enterprise Value for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$17.2 billion.

  • BioNTech SE's Enterprise Value rose 1651.22% to -$17.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.2 billion, marking a year-over-year increase of 1651.22%. This contributed to the annual value of -$17.9 billion for FY2024, which is 1114.78% up from last year.
  • BioNTech SE's Enterprise Value amounted to -$17.2 billion in Q3 2025, which was up 1651.22% from -$15.9 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Enterprise Value ranged from a high of -$1.4 billion in Q3 2021 and a low of -$1459786.9 billion during Q1 2021
  • Over the past 5 years, BioNTech SE's median Enterprise Value value was -$15.9 billion (recorded in 2025), while the average stood at -$76843.2 billion.
  • As far as peak fluctuations go, BioNTech SE's Enterprise Value surged by 9999.99% in 2022, and later plummeted by 71210.88% in 2023.
  • Quarter analysis of 5 years shows BioNTech SE's Enterprise Value stood at -$2.4 billion in 2021, then plummeted by 504.7% to -$14.3 billion in 2022, then tumbled by 40.67% to -$20.2 billion in 2023, then grew by 11.15% to -$17.9 billion in 2024, then rose by 4.15% to -$17.2 billion in 2025.
  • Its Enterprise Value stands at -$17.2 billion for Q3 2025, versus -$15.9 billion for Q2 2025 and -$14.4 billion for Q1 2025.